Temat: "Adenocarcinoma of Lung" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: The application of different machine learning models based on PET/CT images and EGFR in predicting brain metastasis of adenocarcinoma of the lung.
Autorzy:: Kong C; Department of Graduate, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China.
Yin X; Department of Graduate, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China.
Zou J; Department of Graduate, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China.
Ma C; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China. machangsheng_.
Liu K; Department of Head and Neck Comprehensive Radiotherapy, Affiliated Tumor Hospital of Xinjiang Medical University, 830000, Urumqi, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 11; Vol. 24 (1), pp. 454. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/genetics
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Brain Neoplasms*/diagnostic imaging
Humans ; Positron Emission Tomography Computed Tomography ; Retrospective Studies ; Lung/pathology ; ErbB Receptors/genetics ; Machine Learning

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: A nomogram based on the quantitative and qualitative features of CT imaging for the prediction of the invasiveness of ground glass nodules in lung adenocarcinoma.
Autorzy:: Yang Y; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Xu J; Department of Dermatology and Venereal Diseases, Yan'an Hospital of Kunming City, Kunming, China.
Wang W; Department of Thoracic and Cardiovascular Surgery, Shiyan Taihe Hospital (Hubei University of Medicine), Hubei, Shiyan, China.
Ma M; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Huang Q; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Zhou C; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Zhao J; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Duan Y; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Luo J; Department of Pathology, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Jiang J; Department of Radiology, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Ye L; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 09; Vol. 24 (1), pp. 438. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/pathology
Humans ; Nomograms ; Tomography, X-Ray Computed/methods ; Neoplasm Invasiveness/pathology ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Monolayer culture alters EGFR inhibitor response through abrogation of microRNA-mediated feedback regulation.
Autorzy:: Florio A; Biomarker Discovery Laboratory, Center for Individualized Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.
Johnson S; Biomarker Discovery Laboratory, Center for Individualized Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Salvatori R; Biomarker Discovery Laboratory, Center for Individualized Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Vasmatzis G; Biomarker Discovery Laboratory, Center for Individualized Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. .; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7303. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/metabolism
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Antineoplastic Agents*/pharmacology
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Humans ; Erlotinib Hydrochloride/pharmacology ; Erlotinib Hydrochloride/therapeutic use ; Feedback ; ErbB Receptors/metabolism ; Cell Line, Tumor ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Drug Resistance, Neoplasm ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD.
Autorzy:: Xie M; Department of Respiratory and Critical Care, Chinese PLA General Hospital, the First Medical Centre, 100835, Beijing, People's Republic of China.
Gao J; Department of Pathology, Chinese PLA General Hospital, the First Medical Centre, 100835, Beijing, People's Republic of China.
Ma X; Department of Respiratory and Critical Care, Beijing Shijitan Hospital, Capital Medical University, 100038, Beijing, People's Republic of China.
Song J; Department of Respiratory and Critical Care, Weifang Medical College, 261053, Weifang, People's Republic of China.
Wu C; Department of Radiology, Chinese PLA General Hospital, the First Medical Centre, 100835, Beijing, People's Republic of China.
Zhou Y; Department of Respiratory and Critical Care, Beijing Shijitan Hospital, Capital Medical University, 100038, Beijing, People's Republic of China.
Jiang T; Department of Radiology, Affiliated Hospital of Qingdao University, 266500, Qingdao, People's Republic of China.
Liang Y; Department of Respiratory and Critical Care, Beijing Shijitan Hospital, Capital Medical University, 100038, Beijing, People's Republic of China.
Yang C; Department of Laboratory Medicine, Chinese PLA General Hospital, the First Medical Centre, 100835, Beijing, People's Republic of China.
Bao X; Department of Respiratory and Critical Care, Weifang Medical College, 261053, Weifang, People's Republic of China.
Zhang X; Department of Respiratory and Critical Care, Weifang Medical College, 261053, Weifang, People's Republic of China.
Yao J; Department of Respiratory and Critical Care, Beijing Shijitan Hospital, Capital Medical University, 100038, Beijing, People's Republic of China.
Jing Y; Center for Intelligent Medicine, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, 510000, Guangzhou, People's Republic of China. .
Wu J; Department of Radiology, Affiliated Zhongshan Hospital of Dalian University, 116001, Dalian, People's Republic of China. .
Wang J; Department of Respiratory and Critical Care, Chinese PLA General Hospital, the First Medical Centre, 100835, Beijing, People's Republic of China. .
Xue X; Department of Respiratory and Critical Care, Beijing Shijitan Hospital, Capital Medical University, 100038, Beijing, People's Republic of China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 25; Vol. 24 (1), pp. 372. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:: Journal Article
MeSH Terms:: Tertiary Lymphoid Structures*
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Prognosis ; Mutation ; ErbB Receptors/genetics ; ErbB Receptors/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
Autorzy:: Qi H; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Hou Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Zheng Z; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, Shandong, China.
Zheng M; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Qiao Q; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Wang Z; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Sun X; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, Shandong, China.
Xing L; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 21; Vol. 24 (1), pp. 362. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Genes, erbB-1 ; Nomograms ; Progression-Free Survival ; Radiomics ; Magnetic Resonance Imaging ; ErbB Receptors/genetics ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: A new model using deep learning to predict recurrence after surgical resection of lung adenocarcinoma.
Autorzy:: Kim PJ; School of Dentistry and Dental Research Institute, Seoul National University, Seoul, Republic of Korea.
Hwang HS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Choi G; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Sung HJ; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ahn B; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Uh JS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Yoon S; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim D; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Chun SM; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Jang SJ; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Go H; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 16; Vol. 14 (1), pp. 6366. Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Deep Learning*
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Humans ; Neoplasm Recurrence, Local/pathology ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Risk factors and related miRNA phenotypes of chronic pain after thoracoscopic surgery in lung adenocarcinoma patients.
Autorzy:: Zhang L; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Xu L; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Chen Z; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
You H; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Hu H; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
He H; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 14; Vol. 19 (3), pp. e0297742. Date of Electronic Publication: 2024 Mar 14 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Lung Neoplasms*/complications
MicroRNAs*/genetics
Chronic Pain*/genetics
Chronic Pain*/complications
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/complications
Humans ; Prospective Studies ; Quality of Life ; Thoracic Surgery, Video-Assisted/adverse effects ; Pain, Postoperative/genetics ; Pain, Postoperative/prevention & control ; Phenotype ; Pneumonectomy/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Radiological and clinical features of large consolidative-type pulmonary invasive mucinous adenocarcinoma.
Autorzy:: Chen J; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qi L; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang J; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xue L; Department of Diagnostic Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xue Q; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jia J; Department of Diagnostic Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhang G; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu J; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li F; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cui S; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Pokaż więcej
Źródło:: The clinical respiratory journal [Clin Respir J] 2024 Mar; Vol. 18 (3), pp. e13743.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/genetics
Lung Neoplasms*/drug therapy
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Adenocarcinoma, Mucinous*/diagnostic imaging
Adenocarcinoma, Mucinous*/genetics
Adenocarcinoma, Mucinous*/drug therapy
Humans ; Lymphatic Metastasis ; Retrospective Studies ; Proto-Oncogene Proteins p21(ras)/genetics ; Prognosis ; Neoplasm Staging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in lung adenocarcinoma.
Autorzy:: He Z; Department of Radiation Oncology, The first affiliated hospital of Bengbu Medical University, Bengbu, 233000, Anhui, China.
Zhang H; Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University, Shanghai, 200040, China.
Xiao H; Department of Cardiothoracic Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Zhang X; Department of Pathology, Jining First People's Hospital, Jining Medical University, Jining, 272002, Shandong, China.
Xu H; Department of Radiation Oncology, The first affiliated hospital of Bengbu Medical University, Bengbu, 233000, Anhui, China. .
Sun R; Science and Technology Division, Yunnan University of Chinese Medicine, Kunming, 650500, Yunnan, China. .
Li S; Department of Thoracic Surgery, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan, 511500, Guangdong, China. Dr_.; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 29; Vol. 22 (1), pp. 216. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
MicroRNAs*/genetics
Animals ; Humans ; Mice ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Cell Transformation, Neoplastic/genetics ; Gene Expression Regulation, Neoplastic ; Ligases/genetics ; Ligases/metabolism ; RNA/metabolism ; RNA-Binding Proteins/genetics ; RNA-Binding Proteins/metabolism ; Ubiquitin/genetics ; Ubiquitin/metabolism ; Ubiquitination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target.
Autorzy:: Chen M; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, People's Republic of China.
Zhang S; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Wang F; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
He J; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Jiang W; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, People's Republic of China. .
Zhang L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 27; Vol. 22 (1), pp. 209. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma*
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Urea*/analogs & derivatives
Humans ; Benzimidazoles ; Neoplasm Proteins ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Effects of different KRAS mutants and Ki67 expression on diagnosis and prognosis in lung adenocarcinoma.
Autorzy:: Wang J; Department of Thoracic Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310007, China.
Dong L; Department of Thoracic Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310007, China.
Zheng Z; Department of Thoracic Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310007, China.
Zhu Z; Department of Thoracic Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310007, China.
Xie B; Department of Thoracic Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310007, China.
Xie Y; Department of Thoracic Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310007, China.
Li X; Department of Thoracic Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310007, China.
Chen B; Department of Thoracic Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310007, China. .
Li P; Department of Thoracic Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310007, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 19; Vol. 14 (1), pp. 4085. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma of Lung*/diagnosis
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/metabolism
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Proto-Oncogene Proteins p21(ras)*/genetics
Proto-Oncogene Proteins p21(ras)*/metabolism
Humans ; Ki-67 Antigen/genetics ; Ki-67 Antigen/metabolism ; Mutation ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: The innovative checkpoint inhibitors of lung adenocarcinoma, cg09897064 methylation and ZBP1 expression reduction, have implications for macrophage polarization and tumor growth in lung cancer.
Autorzy:: Wang A; Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Zheng WS; Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Luo Z; Department of Pulmonary and Critical Care Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.; Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Bai L; Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Zhang S; Department of Pulmonary and Critical Care Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, China. .; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 18; Vol. 22 (1), pp. 173. Date of Electronic Publication: 2024 Feb 18.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
RNA-Binding Proteins*/genetics
Humans ; Chromatin/metabolism ; Macrophages/metabolism ; Methylation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Lineage-specific intolerance to oncogenic drivers restricts histological transformation.
Autorzy:: Gardner EE; Meyer Cancer Center, Weill Cornell Medicine, New York, NY.
Earlie EM; Meyer Cancer Center, Weill Cornell Medicine, New York, NY.; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY.
Li K; Meyer Cancer Center, Weill Cornell Medicine, New York, NY.
Thomas J; Meyer Cancer Center, Weill Cornell Medicine, New York, NY.
Hubisz MJ; Meyer Cancer Center, Weill Cornell Medicine, New York, NY.; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY.; Bioinformatics Facility, Institute of Biotechnology, Cornell University, Ithaca, NY.
Stein BD; Meyer Cancer Center, Weill Cornell Medicine, New York, NY.; Department of Medicine, Weill Cornell Medicine, New York, NY.
Zhang C; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.
Cantley LC; Meyer Cancer Center, Weill Cornell Medicine, New York, NY.; Department of Medicine, Weill Cornell Medicine, New York, NY.
Laughney AM; Meyer Cancer Center, Weill Cornell Medicine, New York, NY.; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY.
Varmus H; Meyer Cancer Center, Weill Cornell Medicine, New York, NY.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2024 Feb 09; Vol. 383 (6683), pp. eadj1415. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Adenocarcinoma of Lung*/therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Lung Neoplasms*/therapy
Small Cell Lung Carcinoma*/genetics
Small Cell Lung Carcinoma*/pathology
Small Cell Lung Carcinoma*/therapy
Proto-Oncogene Proteins c-myc*/genetics
Proto-Oncogene Proteins c-akt*/genetics
Humans ; Epithelial Cells/pathology ; Lung/pathology ; Oncogenes ; Cell Lineage ; Molecular Targeted Therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Transforming lung cancer types.
Autorzy:: Berns A; Division of Molecular Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2024 Feb 09; Vol. 383 (6683), pp. 590-591. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Oncogenes*
Humans ; Animals ; Mice

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: The association of genomic alterations with PD-L1 expression in Chinese patients with EGFR/ALK wild-type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy.
Autorzy:: Liu F; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang X; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Lu M; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu C; Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
Zhang X; Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen Y; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang P; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e7038.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/therapy
Lung Neoplasms*/therapy
Lung Neoplasms*/drug therapy
Humans ; Anaplastic Lymphoma Kinase/genetics ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; CD8-Positive T-Lymphocytes/metabolism ; China ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Genomics ; Hippo Signaling Pathway/genetics ; Immunotherapy ; Mutation ; Retrospective Studies ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components.
Autorzy:: Li Y; Department of Respiratory Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Zhao J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Zhao Y; Department of Respiratory Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Li R; Department of Respiratory Oncology, Shandong Cancer Hospital and Institute, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, Shan Dong, China.
Dong X; Department of Respiratory Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Yao X; Department of Respiratory Oncology, Shandong Cancer Hospital and Institute, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, Shan Dong, China.
Xia Z; Department of Oncology, Zibo Central Hospital, Binzhou Medical university, Zibo, Shandong, China.
Xu Y; Department of Pathology, Shandong Provincial Hospital Affiliated with Shandong First Medical University, Jinan, Shandong, China.
Li Y; Department of Respiratory Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e7030.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/drug therapy
Lung Neoplasms*/surgery
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/pathology
Humans ; Retrospective Studies ; Neoplasm Staging ; Chemotherapy, Adjuvant

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma.
Autorzy:: Xie L; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Kong H; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yu J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Thoracic Surgery, Shanghai Geriatric Medical Center, Shanghai, China.
Sun M; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Lu S; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang Y; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Hu J; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Du F; Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Lian Q; Gurdon Institute, University of Cambridge, Cambridge, UK.
Xin H; Global Institute of Future Technology, Shanghai Jiao Tong University, Shanghai, China.
Zhou J; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.
Wang X; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institute of Clinical Bioinformatics, Shanghai, China.; Shanghai Engineering Research for AI Technology for Cardiopulmonary Diseases, Fudan University Shanghai Medical College, Shanghai, China.
Powell CA; Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Hirsch FR; Tisch Cancer Institute, Center for Thoracic Oncology, Mount Sinai Health System, New York, New York, USA.
Bai C; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.
Song Y; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.
Yin J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yang D; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.; Pokaż więcej
Źródło:: Clinical and translational medicine [Clin Transl Med] 2024 Feb; Vol. 14 (2), pp. e1573.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lung Neoplasms*/metabolism
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Humans ; B7-H1 Antigen/genetics ; Endothelial Cells/metabolism ; Gene Expression Profiling

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Predictive value of systemic immune-inflammation index in the high-grade subtypes components of small-sized lung adenocarcinoma.
Autorzy:: Wei B; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.
Zhang Y; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China. .
Shi K; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.
Jin X; Laboratory of Respiratory Disease and Thoracic Surgery, KU Leuven, 3000, Leuven, Belgium.
Qian K; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.
Zhang P; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.
Zhao T; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Feb 01; Vol. 19 (1), pp. 39. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Humans ; Retrospective Studies ; Nomograms ; Inflammation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Machine learning-based radiomics to distinguish pulmonary nodules between lung adenocarcinoma and tuberculosis.
Autorzy:: Li Y; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lyu B; CAS Key Laboratory of Behavioral Science, Institute of Psychology, Chinese Academy of Sciences, Beijing, China.
Wang R; Department of Echocardiography, Fuwai Hospital/ National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Peng Y; Department of Thoracic Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Ran H; Department of Cardiothoracic Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhou B; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu Y; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Bai G; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Huai Q; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chen X; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zeng C; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wu Q; Department of Cardiothoracic Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhang C; Department of Cardiothoracic Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Gao S; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (6), pp. 466-476. Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Multiple Pulmonary Nodules*/diagnostic imaging
Multiple Pulmonary Nodules*/pathology
Tuberculosis*
Humans ; Retrospective Studies ; Radiomics ; Tomography, X-Ray Computed/methods ; Machine Learning

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
Autorzy:: Huang Y; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Chen D; Tianjin First Central Hospital Clinic Institute, Tianjin Medical University, Tianjin, 300192, China.
Bai Y; Department of Hepatobiliary Surgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192, China.
Zhang Y; Department of Hepatobiliary Surgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192, China.
Zheng Z; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Fu Q; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Yi B; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Jiang Y; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Zhang Z; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. .
Zhu J; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 11; Vol. 24 (1), pp. 452. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma*
Colonic Neoplasms*
Pancreatic Neoplasms*
Carcinoma, Hepatocellular*
Carcinoma, Renal Cell*/genetics
Adenocarcinoma of Lung*
Thymus Neoplasms*
Liver Neoplasms*
Kidney Neoplasms*
Lung Neoplasms*
Adrenal Cortex Neoplasms*
Humans ; Acetyltransferases ; Chromosomal Proteins, Non-Histone

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Adenocarcinoma of Lung"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język